Status | Study |
Recruiting |
Study Name: Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors Condition: Recurrent Childhood Medulloblastoma Recurrent Childhood Ependymoma Date: 2016-02-11 Interventions: Drug: Intra thecal methotrexate |
Terminated |
Study Name: Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases Condition: Adult Anaplastic (Malignant) Meningioma Adult Anaplastic Astrocytoma Date: 2015-09-13 Interventions: Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging |
Recruiting |
Study Name: Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Condition: Childhood Choroid Plexus Tumor Childhood Ependymoblastoma Date: 2014-09-30 Interventions: Drug: palbociclib isethionate |
Withdrawn |
Study Name: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors Condition: Acoustic Schwannoma Adult Anaplastic Astrocytoma Adult Ana Date: 2014-07-16 Interventions: Radiation: gallium Ga 68-edotreotide |
Recruiting |
Study Name: Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma Condition: Adult Ependymoblastoma Adult Giant Cell Glioblastoma Date: 2013-10-31 Interventions: Radiation: radiation therapy U |
Terminated |
Study Name: Yoga Therapy in Treating Patients With Malignant Brain Tumors Condition: Adult Anaplastic Astrocytoma Adult Anaplastic Ependymoma A Date: 2010-11-03 Interventions: Procedure: yoga therapy Partic |
Completed |
Study Name: RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Condition: Acoustic Schwannoma Adult Anaplastic (Malignant) Meningioma Date: 2010-05-06 Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy |
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-03-16 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Completed |
Study Name: Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 Condition: Anaplastic Astrocytoma Anaplastic Ependymoma Anaplastic Me Date: 2010-03-05 Interventions: Biological: therapeutic allogeneic lymphocytes |
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-02-25 Interventions: Drug: vorinostat Other Names: |